Head of Solid Tumors US Medical Affairs Oncology

Takeda•Boston, MA

1d•$286,900 - $450,890

About The Position

The Head of Solid Tumors, US Medical Affairs is a senior leadership role responsible for developing and executing the US Medical Affairs strategy across the Solid Tumor portfolio, with a primary focus on lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and gastrointestinal (GI) cancers, including gastric cancer and pancreatic ductal adenocarcinoma (PDAC). The role provides strategic medical leadership across priority and emerging disease areas, translating evolving science, clinical practice, and unmet patient needs into an integrated US Medical strategy. The position leads scientific engagement, medical education, field medical strategy, and cross-functional medical planning to support portfolio advancement and organizational readiness. It also provides leadership and development for the Solid Tumor Medical Affairs team and ensures alignment and execution across US Medical Affairs.

Requirements

Advanced scientific or healthcare degree such as PharmD, PhD, MD, or an equivalent relevant advanced degree.
Significant experience in Medical Affairs, clinical development, or a related scientific or medical function within the pharmaceutical or biotechnology industry.
Strong knowledge of oncology and solid tumors.
Strong understanding of the US oncology healthcare environment, including clinical practice, scientific engagement, medical education, and evolving standards of care.
Demonstrated ability to develop and execute Medical Affairs strategies across complex and evolving disease areas.
Ability to interpret complex clinical and scientific data and translate implications into clear strategic priorities and medical plans.
Strong experience engaging external scientific and medical experts and building credible, collaborative relationships within the oncology community.
Demonstrated ability to work effectively across functions and influence strategic decisions within a complex matrix organization.
Strong leadership capabilities, including experience developing teams, coaching colleagues, establishing priorities, and driving accountability.
Excellent executive communication and presentation skills, including the ability to communicate complex scientific and strategic topics clearly to diverse audiences.
Demonstrated strategic thinking, sound judgment, collaboration, and ability to manage multiple priorities in a dynamic environment.
Commitment to scientific integrity, patient impact, ethical decision-making, and compliant Medical Affairs practices.

Nice To Haves

Experience in lung cancer and/or GI malignancies is highly valued.

Responsibilities

Develop and lead the US Medical Affairs strategy for the Solid Tumor portfolio, particularly lung and GI cancers.
Provide strategic medical leadership for NSCLC, including assessment of its treatment landscape, unmet patient needs, scientific priorities, and opportunities to improve patient care.
Lead Medical Affairs assessment and strategic planning for emerging opportunities in SCLC.
Develop and execute US Medical strategies for emerging GI cancer priorities, including gastric cancer and PDAC.
Translate evolving scientific data, clinical practice, treatment guidelines, and the external healthcare environment into actionable US Medical priorities.
Lead integrated medical planning across scientific communications, medical education, external scientific engagement, and field medical priorities.
Establish and maintain strategic scientific engagement with external experts, investigators, academic institutions, professional societies, patient organizations, and other key stakeholders.
Partner with Field Medical leadership to align scientific engagement priorities, capabilities, and execution with the overall US Medical strategy.
Provide medical and scientific leadership across cross-functional teams, partnering as appropriate with Clinical Development, Commercial, Market Access, Biomarkers/Precision Medicine, and Medical Operations.
Represent the US Medical Affairs perspective and patient needs in cross-functional strategic planning and decision-making.
Monitor advances in scientific data, clinical practice, competitive landscapes, and standards of care to identify implications and opportunities for the Solid Tumor portfolio.
Ensure Medical Affairs activities are scientifically rigorous, patient focused, and compliant with applicable policies, standards, and requirements.
Lead, coach, and develop Medical Affairs colleagues, fostering scientific excellence, accountability, collaboration, and high performance.
Establish priorities and allocate resources across the Solid Tumor portfolio to support near- and longer-term objectives.
Serve as a senior US Medical Affairs leader and strategic advisor on important scientific, medical, and portfolio decisions.